Texas Attorney General Greg Abbott announced that the state of Texas and a coalition of 37 states resolved their enforcement action against drug maker GlaxoSmithKline, LLC.
Under a consent judgment entered today, GlaxoSmithKline must pay a total of $90 million to resolve allegations that it unlawfully promoted its diabetes drug, Avandia. The state of Texas will receive $6.2 million under the agreement approved by the court today.
According to the states’ enforcement action, GlaxoSmithKline unlawfully misrepresented Avandia’s cardiovascular risks and safety profile.
Get Breaking News On Your Phone…Text “News” to 80185!
For more Local, Sports, Traffic and Breaking News, LIKE us on Facebook below!